Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | RXRX Recursion Pharmaceuticals, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $3.83 +8.2% | $15.06 -2.0% |
| StockIQ Score | 59C Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 88A | 13F |
| Fundamental | 31F | 35F |
| Growth | 51C- | 50C- |
| Fair Value | 38F | 38F |
| News | 92A+ | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Recursion Pharmaceuticals (RXRX) outperforms Ascentage Pharma (AAPG) in technical and investor scores, with 88 versus 13 and 59 versus 36, respectively. Both share similar valuation scores of 38, but AAPG has a slight edge in growth (50 vs. 51). RXRX’s moderate rating contrasts with AAPG’s weak rating, reflecting stronger overall confidence in its fundamentals and market performance.
